GLYCOSURF LLC

Salt Lake City, UT · Materials · Private

Surfactant-based ligands and ion flotation process for extracting rare earth elements from fracking waste and produced water sludges

New patent ·
Claim this profile

Follows are private to you and power your alerts

Updated · glycosurf.com

Sector
Materials
Headquarters
Salt Lake City, UT
Total capital
$5.7M
Federal grants
$5.7M
12 awards · 2018–2026
Rank in peer group#60 of 84
Private capital raised
None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts
None on recordNo federal contract awards found.
Granted patents
1
1 pending · first 2026
Rank in peer group#25 of 84

Capital timeline

20182020202220242026FEDERAL ↑EQUITY ↓Cumulative $5.7M$1.2M$560K$600K$1M$511K$529K
20182020202220242026FEDERAL ↑EQUITY ↓Cumulative $5.7M$1.2M$600K$1M

Latest events

  • Federal grantHealth and Human S · Phase II · Bioinspired Green Glycolipids as Fugitive Dust Mitigation Agents$529K
  • Federal grantHealth and Human S · Phase II · Bioinspired Green Glycolipids as Fugitive Dust Mitigation Agents$511K
  • Federal grantEnergy · Phase II · Development of Novel Ligands used in Sludge Washing for Produced Water Value Extraction$1M
  • Federal grantHealth and Human S · Phase I · Bioinspired Green Glycolipids as Fugitive Dust Mitigation Agents$173K
  • Federal grantHealth and Human S · Phase I · Bioinspired Green Glycolipids as Fugitive Dust Mitigation Agents$173K
  • Federal grantEnergy · Phase I · Development of Novel Ligands used in Ion Flotation for Produced Water Value Extraction$206K
  • Federal grantEnergy · Phase I · Development of Ligand-Associated Solid-Liquid Extraction Media System for Separation of High Purity Individual Rare Earth Elements from Coal-based Resources$256K
Show 5 earlier federal awards
  • Federal grantHealth and Human S · Phase II · Rhamnolipid-Based Remediation Technologies for Uranium and Rare Earth Element Contamination$600K
  • Federal grantHealth and Human S · Phase II · Rhamnolipid-Based Remediation Technologies for Uranium and Rare Earth Element Contamination$560K
  • Federal grantHealth and Human S · Phase II · Rhamnolipid-Based Remediation Technologies for Uranium and Rare Earth Element Contamination$1.2M
  • Federal grantNSF · Phase I · STTR Phase I: Glycolipids as Inexpensive Solid Supported Ligands for Uranium Remediation$225K
  • Federal grantHealth and Human S · Phase I · Novel Rhamnolipid Surfactants for (Recovery of Critical Elements and) Remediation of Metal Contaminated Waste Streams$225K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 84 peers

Line = median

Materials · Material

  • Federal grantsBelow median
  • Granted patents#25 · top 30%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 1 granted of 2
  • GlycoSurf, LLCShares a founder: Chett J Boxley
  • PRINCETON NUENERGY INCSimilar federal contract value in Materials · null in contracts
  • SALIX LIGNOPOLYMERS, LLCSimilar federal contract value in Materials · null in contracts
  • PD3 TECHNOLOGIES, INC.Similar federal contract value in Materials · null in contracts
  • Glavel, Inc.Similar federal contract value in Materials · null in contracts
  • RETRN BIOWORKS INC.Similar federal contract value in Materials · null in contracts

Regulatory activity · Materials

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .